To determine whether the increased copy number of ACTL6A and BRD9 led to an increase in their expression levels, we acquired two pan-cancer boxplots (Fig 3) regarding the difference of these two genes expression between normal and tumor tissues from Tumor IMmune Estimation Resource (Timer). This evidence concerns the gene BRD9 and neoplasm.